Biogen Inc.BIIBNASDAQ

Overview Intelligence Charts News Fundamentals

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

29 analysts·High coverage

45%

Rating Distribution

Strong Buy

00%

Buy

1345%

Hold

1655%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 12% higher.

Bear Case

$143.00

-22%

Consensus

$206.76

+12%

Bull Case

$250.00

+36%

Price Range29 analysts

Low

Consensus

High

$143.00

$250.00

Current Target

Current Price

$184.02

Upside to Target

$22.74

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$15.77(24 analysts)

P/E21x

Current: 20.9x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev-0.78%

EPS+2.63%

FY2028

Rev+1.23%

EPS+6.75%

FY2029

Rev+0.45%

EPS+3.92%

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+12.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 19, 2026Barclays

Biogen initiated with an Equal Weight at Barclays

Target:$185.00

-3.7%from $192.08

Feb 11, 2026Mizuho Securities

Biogen price target raised to $236 from $207 at Mizuho

Target:$236.00

+24.9%from $188.99

Feb 10, 2026Wedbush

Biogen price target raised to $187 from $178 at Wedbush

Target:$187.00

-3.0%from $192.72

Feb 9, 2026Wolfe Research

Goldman Sachs Reiterates Buy Rating on Biogen (BIIB)

Target:$231.00

+17.9%from $196.00

Feb 9, 2026RBC Capital

Biogen price target raised to $233 from $217 at RBC Capital

Target:$233.00

+18.9%from $195.93

Feb 9, 2026Wolfe Research

Biogen (BIIB) PT Raised to $215 at TD Cowen

Target:$215.00

+10.0%from $195.45

Feb 9, 2026Truist Financial

Biogen price target raised to $193 from $190 at Truist

Target:$193.00

-4.1%from $201.18

Feb 9, 2026Canaccord Genuity

Biogen price target raised to $230 from $220 at Canaccord

Target:$230.00

+14.3%from $201.18

Feb 9, 2026Piper Sandler

Biogen price target raised to $177 from $157 at Piper Sandler

Target:$177.00

-12.0%from $201.18

Feb 9, 2026Guggenheim

Biogen price target raised to $246 from $185 at Guggenheim

Target:$246.00

+22.3%from $201.18

Feb 9, 2026Tudor Pickering

Biogen price target raised to $201 from $191 at Bernstein

Target:$201.00

-0.1%from $201.18

Feb 9, 2026H.C. Wainwright

Biogen price target raised to $228 from $194 at H.C. Wainwright

Target:$228.00

+13.3%from $201.18

Feb 8, 2026Wells Fargo

Biogen price target raised to $200 from $190 at Wells Fargo

Target:$200.00

-0.6%from $201.18

Feb 8, 2026Morgan Stanley

Biogen price target raised to $190 from $156 at Morgan Stanley

Target:$190.00

-5.6%from $201.18

Feb 6, 2026BMO Capital

Biogen price target raised to $196 from $165 at BMO Capital

Target:$196.00

-2.6%from $201.18

Feb 3, 2026Bernstein

Biogen price target lowered to $191 from $197 at Bernstein

Target:$191.00

+6.7%from $179.09

Jan 30, 2026Oppenheimer

Biogen price target raised to $225 from $205 at Oppenheimer

Target:$225.00

+27.7%from $176.18

Jan 8, 2026Truist Financial

Biogen price target raised to $190 from $142 at Truist

Target:$190.00

+2.0%from $186.19

Jan 8, 2026Goldman Sachs

Biogen price target raised to $225 from $197 at Goldman Sachs

Target:$225.00

+20.4%from $186.91

Jan 6, 2026UBS

Biogen assumed with a Neutral at UBS

Target:$185.00

+1.3%from $182.61

Dec 12, 2025Morgan Stanley

Biogen price target raised to $156 from $149 at Morgan Stanley

Target:$156.00

-10.3%from $173.90

Dec 10, 2025HSBC

Biogen downgraded to Reduce from Hold at HSBC

Target:$143.00

-18.7%from $175.80

Nov 21, 2025Piper Sandler

Biogen price target raised to $157 from $118 at Piper Sandler

Target:$157.00

-6.6%from $168.18

Nov 3, 2025Tudor Pickering

Biogen (BIIB) PT Raised to $157 at Bernstein SocGen Group

Target:$157.00

+2.2%from $153.64

Nov 3, 2025Bernstein

Biogen price target raised to $157 from $155 at Bernstein

Target:$157.00

+1.8%from $154.27

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance